Did a new Alzheimer's Disease drug keep this patient's brain healthier for longer?
Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband isn't sure if it made a difference.
Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband isn't sure if it made a difference.
(Image credit: Michael B. Thomas/NPR)
